Cargando…

Delays in surgery for cholesteatoma due to COVID-19: is there an impact on rates of recidivism and major complications?

PURPOSE: To evaluate the relationship between the waiting time for surgery, and cholesteatoma recidivism rates and major complications. The secondary aims were to identify any other prognostic factors for cholesteatoma recidivism. METHODS: A retrospective single-centre study of 312 patients who unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Mohammed Hassan, Mair, Manish, Mahmood, Sara, Sakagiannis, Georgios, Rojoa, Djamila M., Raheman, Firas J., Irvine, Esmee, Rea, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547560/
https://www.ncbi.nlm.nih.gov/pubmed/33040233
http://dx.doi.org/10.1007/s00405-020-06416-7
_version_ 1783592445618946048
author Hussain, Mohammed Hassan
Mair, Manish
Mahmood, Sara
Sakagiannis, Georgios
Rojoa, Djamila M.
Raheman, Firas J.
Irvine, Esmee
Rea, Peter
author_facet Hussain, Mohammed Hassan
Mair, Manish
Mahmood, Sara
Sakagiannis, Georgios
Rojoa, Djamila M.
Raheman, Firas J.
Irvine, Esmee
Rea, Peter
author_sort Hussain, Mohammed Hassan
collection PubMed
description PURPOSE: To evaluate the relationship between the waiting time for surgery, and cholesteatoma recidivism rates and major complications. The secondary aims were to identify any other prognostic factors for cholesteatoma recidivism. METHODS: A retrospective single-centre study of 312 patients who underwent cholesteatoma surgery under the care of a single-surgeon, between 2004 and 2018, was performed. Waiting times for surgery were categorised into ≤ 90 days, 91–180 days, 181–270 days and > 271 days. The outcome measures were cholesteatoma recidivism and major complications (facial nerve palsy or intracranial complications). RESULTS: The mean age was 36.1 years ± 21.5 with 242 adults (77.6%) and 70 children (22.4%). The mean waiting time for surgery was 126.2 days (4.1 months) ± 96.0 days and the overall rate of recidivism was 11.2% (35/312 patients). No instances of facial nerve palsy or intracranial complications were identified. Rates of recidivism by waiting time for surgery were: 15.3% for 118 patients who waited ≤ 90 days, 9.7% for 134 patients who waited 91–180 days, 6.7% for 30 patients who waited 181–270 days and 4.3% for 23 patients who waited > 271 days. There was no significant difference amongst the different waiting time groups for rates of recidivism (p = 0.266). CONCLUSION: Increased waiting times for cholesteatoma surgery do not appear to be associated with increased rates of recidivism or major complications. Clinical judgement will always be required for complicated disease or patients with additional risk factors. The other prognostic factors for recidivism identified in this study were age (< 15 years) and congenital cholesteatoma. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00405-020-06416-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7547560
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-75475602020-10-14 Delays in surgery for cholesteatoma due to COVID-19: is there an impact on rates of recidivism and major complications? Hussain, Mohammed Hassan Mair, Manish Mahmood, Sara Sakagiannis, Georgios Rojoa, Djamila M. Raheman, Firas J. Irvine, Esmee Rea, Peter Eur Arch Otorhinolaryngol Otology PURPOSE: To evaluate the relationship between the waiting time for surgery, and cholesteatoma recidivism rates and major complications. The secondary aims were to identify any other prognostic factors for cholesteatoma recidivism. METHODS: A retrospective single-centre study of 312 patients who underwent cholesteatoma surgery under the care of a single-surgeon, between 2004 and 2018, was performed. Waiting times for surgery were categorised into ≤ 90 days, 91–180 days, 181–270 days and > 271 days. The outcome measures were cholesteatoma recidivism and major complications (facial nerve palsy or intracranial complications). RESULTS: The mean age was 36.1 years ± 21.5 with 242 adults (77.6%) and 70 children (22.4%). The mean waiting time for surgery was 126.2 days (4.1 months) ± 96.0 days and the overall rate of recidivism was 11.2% (35/312 patients). No instances of facial nerve palsy or intracranial complications were identified. Rates of recidivism by waiting time for surgery were: 15.3% for 118 patients who waited ≤ 90 days, 9.7% for 134 patients who waited 91–180 days, 6.7% for 30 patients who waited 181–270 days and 4.3% for 23 patients who waited > 271 days. There was no significant difference amongst the different waiting time groups for rates of recidivism (p = 0.266). CONCLUSION: Increased waiting times for cholesteatoma surgery do not appear to be associated with increased rates of recidivism or major complications. Clinical judgement will always be required for complicated disease or patients with additional risk factors. The other prognostic factors for recidivism identified in this study were age (< 15 years) and congenital cholesteatoma. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00405-020-06416-7) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-10-10 2021 /pmc/articles/PMC7547560/ /pubmed/33040233 http://dx.doi.org/10.1007/s00405-020-06416-7 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Otology
Hussain, Mohammed Hassan
Mair, Manish
Mahmood, Sara
Sakagiannis, Georgios
Rojoa, Djamila M.
Raheman, Firas J.
Irvine, Esmee
Rea, Peter
Delays in surgery for cholesteatoma due to COVID-19: is there an impact on rates of recidivism and major complications?
title Delays in surgery for cholesteatoma due to COVID-19: is there an impact on rates of recidivism and major complications?
title_full Delays in surgery for cholesteatoma due to COVID-19: is there an impact on rates of recidivism and major complications?
title_fullStr Delays in surgery for cholesteatoma due to COVID-19: is there an impact on rates of recidivism and major complications?
title_full_unstemmed Delays in surgery for cholesteatoma due to COVID-19: is there an impact on rates of recidivism and major complications?
title_short Delays in surgery for cholesteatoma due to COVID-19: is there an impact on rates of recidivism and major complications?
title_sort delays in surgery for cholesteatoma due to covid-19: is there an impact on rates of recidivism and major complications?
topic Otology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547560/
https://www.ncbi.nlm.nih.gov/pubmed/33040233
http://dx.doi.org/10.1007/s00405-020-06416-7
work_keys_str_mv AT hussainmohammedhassan delaysinsurgeryforcholesteatomaduetocovid19isthereanimpactonratesofrecidivismandmajorcomplications
AT mairmanish delaysinsurgeryforcholesteatomaduetocovid19isthereanimpactonratesofrecidivismandmajorcomplications
AT mahmoodsara delaysinsurgeryforcholesteatomaduetocovid19isthereanimpactonratesofrecidivismandmajorcomplications
AT sakagiannisgeorgios delaysinsurgeryforcholesteatomaduetocovid19isthereanimpactonratesofrecidivismandmajorcomplications
AT rojoadjamilam delaysinsurgeryforcholesteatomaduetocovid19isthereanimpactonratesofrecidivismandmajorcomplications
AT rahemanfirasj delaysinsurgeryforcholesteatomaduetocovid19isthereanimpactonratesofrecidivismandmajorcomplications
AT irvineesmee delaysinsurgeryforcholesteatomaduetocovid19isthereanimpactonratesofrecidivismandmajorcomplications
AT reapeter delaysinsurgeryforcholesteatomaduetocovid19isthereanimpactonratesofrecidivismandmajorcomplications